Methylprednisolone

Subscribe to Selected New Research on Methylprednisolone

3806 relevant articles (522 outcomes, 537 trials/studies) found for this Drug

Description: A PREDNISOLONE derivative with similar anti-inflammatory action.

Also Known As:

6-Methylprednisolone; Medrol; Metipred; Urbason; 6 Methylprednisolone; Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6alpha,11beta)-

Relationship Network

Drug Context: Research Results

Experts

1.	Cetin, Mualla: 4 articles (03/2008 - 07/2003)
2.	Suzuki, Junzo: 4 articles (03/2007 - 04/2003)
3.	Suzuki, Hitoshi: 4 articles (03/2007 - 04/2003)
4.	Kawasaki, Yukihiko: 4 articles (03/2007 - 04/2003)
5.	Hiçsönmez, Gönül: 4 articles (09/2005 - 01/2002)
6.	Sellebjerg, F: 4 articles (02/2003 - 05/2000)
7.	Rzany, Berthold: 3 articles (12/2007 - 09/2005)
8.	Derksen, Ronald H W M: 3 articles (08/2007 - 03/2007)
9.	Grootscholten, Cecile: 3 articles (08/2007 - 03/2007)
10.	Berden, Jo H M: 3 articles (08/2007 - 03/2007)

Related Diseases

1.	Nephrotic Syndrome (Syndrome, Nephrotic) 03/01/1999 - "This study was done to determine the efficacy of oral high dose methylprednisolone (HDMP) therapy in the treatment of childhood nephrotic syndrome (NS). " 03/01/2009 - "The steroid resistance of nephrotic syndrome is defined by the absence of remission after a full dose of oral corticosteroid therapy for 1 month followed by 3 pulses of intravenous methylprednisolone. " 11/01/2004 - "Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome." 01/01/1989 - "Following methylprednisolone therapy, nephrotic syndrome remission was achieved only in three patients with minimal change disease. " 09/16/2004 - "[Posterior reversible encephalopathy in a 12-year-old female with nephrotic syndrome and methylprednisolone therapy]" Order ALL the reference details at left...
2.	Spinal Cord Injuries (Spinal Cord Injury) 10/01/1994 - "The National Acute Spinal Cord Injury Study II concluded in 1990 that high-dose methylprednisolone (MP) improved neurologic recovery after acute spinal cord injury (ASCI). " 11/01/1985 - "A multi-center double-blind randomized clinical trial was conducted by the National Acute Spinal Cord Injury Study Group to examine the efficacy of high-dose methylprednisolone (1000-mg bolus and 1000 mg daily thereafter for 10 days) compared with that of a standard dose (100-mg bolus and 100 mg daily for 10 days). " 01/06/1984 - "A multicenter double-blind randomized trial was conducted to examine the efficacy of a high dose of methylprednisolone (1,000-mg bolus and daily thereafter for ten days) compared with a standard dose (100-mg bolus and daily thereafter for ten days) in 330 patients with acute spinal cord injury. " 01/01/2000 - "BACKGROUND: High-dose intravenously administered methylprednisolone has been shown to improve outcome after spinal cord injury. " 07/01/1999 - "Clinically, high-dose treatment with the glucocorticosteroid, methylprednisolone (MP), within 8 h after spinal cord injury, has been shown to improve neurological recovery. " Order ALL the reference details at left...
3.	Pain (Aches) 03/01/2007 - "CONCLUSION: In the case of lumbar radicular pain, ESI with low dose (40 mg) methylprednisolone is as effective as high dose (80 mg) with comparable results and less adverse profile." 06/05/1997 - "After six weeks, the only significant difference was the improvement in leg pain, which was greater in the methylprednisolone group (P=0.03). " 03/01/1987 - "In both groups a statistically significant improvement of pain on mobilisation and pain index was noted, but the number of clinical remissions was significantly higher in the methylprednisolone group. " 01/01/2002 - "CONCLUSION: These results suggest that periarticular injection of methylprednisolone may be effective in the treatment of pain in the region of the SIJ in non-spondylarthropathic patients." 08/15/2008 - "The primary outcome, a comparison of the mean improvement in pain intensity, favored methylprednisolone by 1.3 (P = 0.10). " Order ALL the reference details at left...
4.	Vomiting 01/04/2007 - "Oral antihistamine was administered initially, but without improvement in symptoms and signs until intravenous methylprednisolone 500 mg. Recurrence occurred after two hours, plus vomiting. " 09/01/1984 - "Effect of methylprednisolone on the emesis of patients treated with CDDP was examined by randomized control trial. " 09/01/1984 - "[Randomized control study of methylprednisolone in the prevention of CDDP-induced emesis]" 04/01/2003 - "The vomiting was successfully treated with a short course of methylprednisolone. " 09/01/1996 - "At cycle 2, patients also received methylprednisolone showing complete protection from vomiting in 19 cases (47%) and major protection on 12 cases (30%). " Order ALL the reference details at left...
5.	Multiple Sclerosis 06/01/1995 - "It is important for medical-surgical nurses to understand the pathophysiology of multiple sclerosis, as well as recent evidence suggesting that intravenous methylprednisolone treatment may be effective for treating exacerbations of the disease. " 02/01/1988 - "This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis." 03/01/2002 - "OBJECTIVE: To investigate the efficacy of two different high doses of intravenous methylprednisolone (IVMP) during Multiple Sclerosis (MS) relapses. " 07/01/1996 - "High dose intravenous methylprednisolone treatment is effective and safe in the treatment of relapses in multiple sclerosis, but the long term effects are unclear. " 06/01/1994 - "The demonstration of efficacy for both of these agents represent landmarks in the search for an effective treatment for multiple sclerosis; both agents seem to provide prophylaxis against future relapses, and methylprednisolone seems to delay the development of the disease. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Cyclophosphamide (Cytoxan)
2.	Prednisolone (Predate)
3.	Prednisone (Sone)
4.	Cyclosporine (Ciclosporin)
5.	Adrenal Cortex Hormones (Corticosteroids)
6.	Dexamethasone (Maxidex)
7.	Azathioprine (Imuran)
8.	Chlorambucil (Leukeran)
9.	Immunoglobulins (Immunoglobulin)
10.	Metoclopramide (Reglan)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Plasma Exchange
3.	Plasmapheresis
4.	Tonsillectomy
5.	Aftercare (After-Treatment)

Best Treatments:
Research Summary Report
on Nephrotic Syndrome

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 577 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapi